MedTrace Logo

Development of a New Impedance Mapping System for Ablation of Atrial Arrhythmias in Patients

NCT05159180 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2021-12-20

No results posted yet for this study

Summary

Precise identification of the atrial fibrosis is essential for successful catheter ablation of atrial arrhythmias in patients with atrial fibrillation. Voltage mapping of endocardial electrograms is currently used to delineate the anatomical substrate, but this is influenced by the direction of the activation wave front and is limited by the patient-specific thresholds. Mapping of local myocardial electrical impedance may overcome these limitations.

Conditions

  • Atrial Fibrillation and Flutter
  • Atrial Arrhythmia
  • Atrial Fibrillation Recurrent

Interventions

DEVICE

cardioz mapping

Patients will be submitted to mapping of both voltage and tissue impedance.

Sponsors & Collaborators

  • Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-13
Primary Completion
2022-07-31
Completion
2022-12-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05159180 on ClinicalTrials.gov